JPRN-jRCT2032220217进行中（未招募）未知
Multicenter, Randomized, Double-blind, Pseudo-placebo-controlled, Parallel-group Confirmatory Clinical Trial to Evaluate the Efficacy and Safety of TLG-001J in Myopic Schoolchildren
Tsubota Kazuo0 个研究点目标入组 160 人开始时间: 2022年7月16日最近更新:
适应症
试验速览
- 阶段
- 未知
- 状态
- 进行中（未招募）
- 发起方
- 入组人数
- 160
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Interventional
入排标准
- 年龄范围
- >= 6age old 至 <= 12age old（—）
- 性别
- All
入选标准
- •Male and female Japanese schoolchildren who are 6 to 12 years old at the time of informed consent
- •- Anisometropia is within 1.50 D
- •- Astigmatism, cycloplegic objective refraction (C), is within +/- 1.50 D for each eye
排除标准
- •- A history of refractive and/or other form of ophthalmic surgery
- •- Impaired binocular visual function
- •- Amblyopia or manifest strabismus
- •- Individuals who are likely to require contact lenses (e.g., monofocal, bifocal, orthokeratology) or multifocal eyeglasses during the trial
研究者
相似试验
未知
3 期
Compare the Efficacy and Safety of Donepezil Hydrochloride 23 mg Treatment With Continuation of Donepezil Hydrochloride 10 mg Treatment in Japanese Subjects With Severe Alzheimer's DiseaseSevere Alzheimer's Type DementiaJPRN-jRCT2080221731Eisai Co., Ltd.330
进行中（未招募）
1 期
Rivaroxaban versus Aspirin in secondary prevention of stroke and prevention of systemic embolism in patients with recent embolic stroke of undetermined source (ESUS)Embolic stroke of undetermined source (ESUS)MedDRA version: 19.0Level: PTClassification code 10014498Term: Embolic strokeSystem Organ Class: 10029205 - Nervous system disordersEUCTR2013-000768-27-HUBayer AG7,000
进行中（未招募）
1 期
Rivaroxaban versus Aspirin in secondary prevention of stroke and prevention of systemic embolism in patients with recent embolic stroke of undetermined source (ESUS)EUCTR2013-000768-27-GRBayer HealthCare AG7,000
进行中（未招募）
1 期
Rivaroxaban versus Aspirin in secondary prevention of stroke and prevention of systemic embolism in patients with recent embolic stroke of undetermined source (ESUS)Embolic stroke of undetermined source (ESUS)MedDRA version: 17.0Level: PTClassification code 10014498Term: Embolic strokeSystem Organ Class: 10029205 - Nervous system disordersEUCTR2013-000768-27-SEBayer HealthCare AG7,000
进行中（未招募）
1 期
Rivaroxaban versus Aspirin in secondary prevention of stroke and prevention of systemic embolism in patients with recent embolic stroke of undetermined source (ESUS)Embolic stroke of undetermined source (ESUS)MedDRA version: 18.1 Level: PT Classification code 10014498 Term: Embolic stroke System Organ Class: 10029205 - Nervous system disordersEUCTR2013-000768-27-PTBayer HealthCare AG7,213